Which of the following diseases has the highest risk of developing resistance under inadequate treatment?
A A. The treatment plan should include at least 4 drugs, and the efficacy of the drugs should be confirmed B. When deciding whether to use mesalazine and ethionamide in the individualized treatment plan, doctors should not rely on drug susceptibility test results C. An injection should be used for at least 6 months and should be used for at least 4 months after sputum smear becomes negative D. After sputum smear becomes negative, the shortest treatment course should be 18 months E. All of the above statements are true 15. About the result of MDR-TB, please listen to each of the following statements and decide whether it is true or false?
A. Patients who have been treated with second-line drugs in the past may be hard to cure B. Patients with isolates resistant to fluoroquinolone may be hard to cure C. Previous treatment with ofloxacin does not affect the outcome of MDR-TB D. Loss to follow-up is one of the major challenges in the treatment of MDR-TB E. None of the above statements are false
